HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naohisa Hosomi Selected Research

Indicators and Reagents (Reagents)

1/2020Increased blood pressure variability during the subacute phase of ischemic stroke is associated with poor functional outcomes at 3 months.
11/2018Controlling nutritional status score for predicting 3-mo functional outcome in acute ischemic stroke.
1/2016Prediction of Pneumonia in Acute Stroke Patients Using Tongue Pressure Measurements.
3/2015CD34+/CD144+ circulating endothelial cells as an indicator of carotid atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naohisa Hosomi Research Topics

Disease

43Stroke (Strokes)
11/2022 - 10/2004
32Ischemic Stroke
05/2022 - 10/2004
14Hypertension (High Blood Pressure)
04/2018 - 06/2009
9Atherosclerosis
10/2020 - 05/2002
9Embolic Stroke
03/2018 - 05/2007
7Neoplasms (Cancer)
01/2022 - 06/2009
7Infarction (Infarctions)
06/2021 - 08/2005
7Brain Ischemia (Cerebral Ischemia)
07/2017 - 12/2003
5Transient Ischemic Attack
05/2019 - 07/2014
5Diabetes Mellitus
04/2018 - 05/2002
4Atrial Fibrillation
03/2022 - 01/2008
4Cerebral Hemorrhage
01/2022 - 01/2010
4Carotid Artery Diseases
06/2018 - 10/2004
4Hyperlipidemias (Hyperlipidemia)
04/2018 - 07/2012
3Hemorrhage
01/2020 - 05/2007
3Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2018 - 10/2004
3Heart Failure
01/2016 - 12/2008
3Hypertrophy
01/2012 - 01/2011
3Brain Edema (Cerebral Edema)
11/2011 - 08/2005
3Fibrosis (Cirrhosis)
09/2009 - 03/2006
2Alcoholism (Alcohol Abuse)
04/2024 - 02/2014
2Hypertensive Intracranial Hemorrhage
01/2022 - 01/2021
2Malnutrition (Nutritional Deficiencies)
09/2020 - 11/2018
2Lacunar Stroke
05/2020 - 01/2018
2Brain Infarction
01/2019 - 08/2005
2Fabry Disease (Fabry's Disease)
12/2018 - 03/2009
2Venous Thrombosis (Deep-Vein Thrombosis)
03/2018 - 09/2016
2Inflammation (Inflammations)
10/2017 - 10/2009
2Dyslipidemias (Dyslipidemia)
01/2016 - 01/2011
2Neurodegenerative Diseases (Neurodegenerative Disease)
06/2014 - 04/2011
2Cognitive Dysfunction
05/2013 - 03/2011
2Heart Diseases (Heart Disease)
01/2013 - 01/2011
2Edema (Dropsy)
05/2012 - 01/2010
2Insulin Resistance
10/2011 - 09/2009
2Diabetic Nephropathies (Diabetic Nephropathy)
03/2010 - 09/2008
2Type 2 Diabetes Mellitus (MODY)
07/2009 - 05/2002
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2005 - 12/2003
1Intracranial Embolism
02/2024
1Brain Diseases (Brain Disorder)
01/2024
1Acute Kidney Injury (Acute Renal Failure)
01/2024
1Allergic Rhinitis
12/2022
1Aspiration Pneumonia
01/2022
1Hypoalbuminemia
01/2022
1Thrombophilia
01/2022
1Dental Caries (Decay, Dental)
01/2022

Drug/Important Bio-Agent (IBA)

14Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2020 - 02/2014
11Pravastatin (Pravachol)FDA LinkGeneric
06/2020 - 02/2014
9Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2008
7Brain Natriuretic Peptide (Natrecor)FDA Link
05/2016 - 01/2004
6AnticoagulantsIBA
09/2018 - 05/2007
5Immunoglobulin G (IgG)IBA
03/2022 - 08/2005
5C-Reactive ProteinIBA
05/2019 - 01/2011
4CholesterolIBA
04/2024 - 02/2014
4AlbuminsIBA
04/2024 - 09/2008
4Proteins (Proteins, Gene)FDA Link
11/2022 - 09/2009
4fibrin fragment D (D-dimer)IBA
01/2022 - 01/2011
4LDL CholesterolIBA
05/2020 - 04/2016
4Indicators and Reagents (Reagents)IBA
01/2020 - 03/2015
4Heparin (Liquaemin)FDA LinkGeneric
09/2018 - 05/2007
4Antihypertensive Agents (Antihypertensives)IBA
01/2017 - 01/2012
4Blood Glucose (Blood Sugar)IBA
12/2015 - 12/2007
4Angiotensin IIIBA
11/2011 - 09/2008
3AntibodiesIBA
03/2022 - 12/2019
3CollagenIBA
01/2022 - 03/2011
3LDL Lipoproteins (beta Lipoproteins)IBA
05/2020 - 01/2018
3danaparoid (Orgaran)FDA Link
03/2018 - 01/2011
3Hemoglobins (Hemoglobin)IBA
06/2017 - 07/2012
3Tissue Plasminogen Activator (Alteplase)FDA Link
12/2015 - 12/2003
3SaltsIBA
05/2013 - 03/2006
3olmesartanIBA
05/2013 - 03/2006
3Glucose (Dextrose)FDA LinkGeneric
05/2012 - 05/2002
3AldosteroneIBA
09/2009 - 03/2006
3Matrix Metalloproteinases (MMPs)IBA
05/2009 - 12/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2009 - 08/2005
2Carrier Proteins (Binding Protein)IBA
01/2022 - 01/2021
2Serum AlbuminIBA
09/2020 - 11/2018
2EnzymesIBA
12/2018 - 03/2009
2cilnidipineIBA
06/2018 - 01/2017
2Warfarin (Coumadin)FDA LinkGeneric
09/2016 - 01/2015
2Ethanol (Ethyl Alcohol)IBA
02/2014 - 09/2009
2Angiotensin Receptor AntagonistsIBA
11/2013 - 11/2011
28-Hydroxy-2'-DeoxyguanosineIBA
01/2013 - 01/2012
2AntigensIBA
05/2012 - 12/2003
2Peptide Hydrolases (Proteases)FDA Link
05/2012 - 12/2003
2Insulin (Novolin)FDA Link
10/2011 - 12/2007
2ReninIBA
04/2011 - 09/2009
2Messenger RNA (mRNA)IBA
03/2011 - 12/2003
2ThrombinFDA Link
01/2010 - 05/2007
2Drinking WaterIBA
09/2009 - 09/2008
1Thiamine (Aneurin)FDA Link
04/2024
1DabigatranFDA Link
02/2024
1Acyclovir (Aciclovir)FDA LinkGeneric
01/2024
1Valacyclovir (Valtrex)FDA LinkGeneric
01/2024
1AllergensIBA
12/2022
1Alkaline PhosphataseIBA
05/2022
1CarbohydratesIBA
01/2022
1Tumor Biomarkers (Tumor Markers)IBA
01/2022
1Dexamethasone Isonicotinate (HE 111)IBA
01/2022

Therapy/Procedure

11Therapeutics
01/2022 - 01/2008
4Secondary Prevention
01/2019 - 02/2014